Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine

NCT02120326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether TDCS is an effective prophylactic therapy of chronic migraine.

Conditions

  • Chronic Migraine as Defined by Criteria of International Headache Society (IHS)

Interventions

DEVICE

Transcranial direct current stimulation of the motor cortex

The area of stimulation is determined by by EEG system 10/20. The two electrodes are soaked in saline and then placed on the scalp. Stimulation parameters: * 2 mA intensity * Continuous stimulation for 20 min with rise times and fall times of 10 seconds each

DEVICE

simulation of Transcranial direct current stimulation of the motor cortex

The area of stimulation is determined by by EEG system 10/20. The two electrodes are soaked in saline and then placed on the scalp. Stimulation parameters: * The intensity of the stimulation current is 2 mA * The current is applied during the first 30 seconds with rise times and fall times of 10 seconds each. Then the session will be continued without actual stimulation.

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • HODAJ Hasan, MD · University Hospital, Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-05
Primary Completion
2019-12-18
Completion
2020-06-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02120326 on ClinicalTrials.gov